Merck Seeks US FDA Approval For Keytruda To Treat Non-Small Lung Cancer
Merck, which is known as MSD outside of Canada and the United States has announced that, the US FDA has approved for reviewing a new supplemental Biologics Licence Application (sBLA) seeking a new review for the Keytruda for the treatment of the patients with the non-small cell lung cancer followed by the complete surgical resection. […]
Continue Reading